Drug Profile
Research programme: antisense oligonucleotides and monoclonal antibody therapeutics - Gene Signal
Alternative Names: GS-156 mAB; GS-156 Small peptide; GS-168; GS-326; GS-497CLatest Information Update: 23 Feb 2023
Price :
$50
*
At a glance
- Originator Gene Signal
- Class Antisense oligonucleotides
- Mechanism of Action Gene expression inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Wounds
- Discontinued Lung cancer; Pancreatic cancer; Renal cancer
Most Recent Events
- 23 Feb 2023 Discontinued - Preclinical for Lung cancer in France (Parenteral)
- 28 Oct 2019 No recent reports of development identified for preclinical development in Lung-cancer in France (Parenteral)
- 28 Oct 2019 No recent reports of development identified for research development in Cancer in France (Parenteral)